• Renee Stein, Songli Xu, Weston Williams, Mariette Marano, Adanze Eke, Teresa Finlayson, Gabriela Paz-Bailey, Cyprian Wejnert, and NHBS study group.
• Centers for Disease Control and Prevention, 1600 Clifton Road, US8-2, Atlanta, GA, 30333, USA. arf7@cdc.gov.
• J Urban Health. 2019 Dec 1; 96 (6): 868-877.

AbstractReducing HIV among men who have sex with men (MSM) is a national goal, and early diagnosis, timely linkage to HIV medical care, and ongoing care and treatment are critical for improving health outcomes for MSM with HIV and preventing transmission to others. We assessed demographic, social, and economic factors associated with HIV antiretroviral treatment among HIV-infected MSM. Data are from the National HIV Behavioral Surveillance (NHBS) collected in 2014 among MSM. We estimated prevalence ratios and 95% confidence intervals using average marginal predictions from logistic regression. Overall, 89% of HIV-positive MSM reported currently taking antiretroviral therapy (ART). After controlling for other variables, we found that higher perceived community stigma and not having health insurance were significant risk factors for not taking ART. We also found that high socioeconomic status (SES) was associated with taking ART. Race/ethnicity was not significantly associated with taking ART in either the unadjusted or adjusted analyses. Findings suggest that to increase ART use for MSM with HIV, we need to move beyond individual-level approaches and move towards the development, dissemination, and evaluation of structural and policy interventions that respond to these important social and economic factors.

30 keywords...

hide…